NHS National Framework Agreement for Macitentan & Cladribine Tablets
NHS England · Upcoming
- Buyer
- NHS England
- Status
- Upcoming
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-0668c2
- Published
- 2026-11-03
Tender summary
UK2 Preliminary market engagement notice — early notice of a future procurement; not yet open for bids. Market engagement closes 17 Nov 2026. Tender expected from 27 Jan 2027. Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets Offer reference number: CM/TNS/26/5748 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5748/01 Macitentan Lot 1 DCE/DLN: 01/10/2027 to 30/09/2029 (24 months) CELN Lot 2 DNW/DLS: 01/10/2027 to 31/01/2029 (16 months) NWLS…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access